Healthcare Services

Global Oncologists Market Expected to Reach $25.06 Billion by 2030 with 4.4% CAGR

April 3, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

How Is The Market Size Of The Oncologists Market Expected To Change Between 2026 And 2030?

The oncologists market size has seen steady growth in recent years. It is anticipated to expand from $20.21 billion in 2025 to $21.09 billion in 2026, achieving a compound annual growth rate (CAGR) of 4.4%. The factors contributing to this growth in the past include the increasing worldwide incidence of cancer, a rising demand for specialized oncology treatments, the expansion of hospital and clinic networks, improvements in diagnostic imaging technologies, and enhanced awareness of early cancer detection.

The oncologists market size is projected to experience consistent expansion in the coming years. This market is anticipated to reach $25.07 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 4.4%. This anticipated expansion throughout the forecast period stems from several factors, including the advancement of personalized and targeted cancer treatments, the uptake of digital solutions for oncology management, breakthroughs in immunotherapy and targeted therapy technologies, the establishment of more oncology centers in developing regions, and the greater application of genomics and molecular diagnostics for tailoring treatment plans. Key trends during this period encompass the growing use of digital oncology platforms for managing patients, a rise in the integration of AI and machine learning for cancer diagnosis, the expanding deployment of precision medicine and genomic profiling for customized cancer treatment, increased automation in the preparation and delivery of chemotherapy, and greater IoT-enabled surveillance of oncology equipment and patient information.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=9474&type=smp

Which Major Factors Are Driving The Expansion Of The Oncologists Market?

The increasing incidence of cancer is anticipated to boost the oncologists market in the future. Cancer is defined as a condition where certain body cells multiply without control and extend to different regions. The prevalence of cancer denotes the quantity of new cancer diagnoses appearing within a defined population over a particular timeframe. Oncologists are medical professionals specializing in identifying and treating cancer. Their roles include patient examination, cancer diagnosis, and determining suitable treatment plans. As an example, in May 2024, the National Cancer Institute, a US-based government entity, reported approximately 18.1 million cancer survivors in the United States. This number is forecasted to increase to 22.5 million by 2032. By 2040, new annual cancer cases are predicted to reach 29.9 million, and cancer-related fatalities are projected to grow to 15.3 million. Consequently, the increasing incidence of cancer is a key driver for the oncologists market.

How Is The Oncologists Market Structured Across Different Segments?

The oncologists market covered in this report is segmented –

1) By Cancer Diagnostics And Treatment: Cancer Diagnostics, Cancer Treatment

2) By Indication: Lungs Cancer, Colorectal Cancer, Breast Cancer, Liver Cancer, Bladder Cancer, Head And Neck Cancer, Prostate Cancer, Other Indications

3) By End Use: Hospitals, Diagnostic Laboratories, Diagnostic Imaging Centers, Specialty Clinics, Academia, Other End Uses

Subsegments:

1) By Cancer Diagnostics: Imaging Tests, Biopsy, Blood Tests, Molecular Diagnostics, Genetic Testing

2) By Cancer Treatment: Chemotherapy, Radiation Therapy, Immunotherapy, Targeted Therapy, Hormone Therapy, Stem Cell Transplant

What Key Trends Are Influencing The Development Of The Oncologists Market?

Leading companies in the oncologists market are concentrating on establishing AI-precision oncology centers to enhance personalized cancer care, improve diagnostic accuracy, and optimize treatment plans based on individual patient data and tumor characteristics. AI-precision oncology centers are defined as specialized medical facilities that employ artificial intelligence (AI) and machine learning technologies to deliver highly individualized cancer treatment. For instance, in January 2024, Apollo Cancer Centre, an India-based hospital, launched Apollo Cancer Centre. This center is designed to assist oncologists, patients, and caregivers in achieving the best possible outcomes within a defined timeframe by leveraging the extensive potential of AI technology. The center utilizes AI technologies to provide precise diagnoses and real-time insights into patient conditions. This capability allows for timely interventions and improved management of cancer cases. Additionally, the centre conducts comprehensive cancer risk assessments, helping to identify patients who may benefit from targeted therapies or immunotherapy as part of their treatment plans.

Which Major Players Dominate The Oncologists Market?

Major companies operating in the oncologists market are Abramson Cancer Center, MD Anderson Cancer Center of the University of Texas, Lilavati Hospital & Research Centre, Mount Elizabeth Hospital, Mount Miriam Cancer Hospital, Charité – Universitätsmedizin Berlin, General Electric Healthcare, F. Hoffmann-La Roche AG, Pfizer Inc., Bayer AG, Merck & Co. Inc., AbbVie Inc., Amgen Inc., Takeda Pharmaceuticals USA Inc., Becton Dickinson and Company, Cook Medical LLC, Terumo Corporation, AngioDynamics Inc., Thermo Fisher Scientific Inc., Illumina Inc., Bristol-Myers Squibb Company, AstraZeneca plc, Novartis AG, Eli Lilly and Company, Gilead Sciences Inc., Regeneron Pharmaceuticals Inc., Incyte Corporation, Seattle Genetics Inc.

Read the full oncologists market report here:

https://www.thebusinessresearchcompany.com/report/oncologists-global-market-report

Which Region Currently Holds The Largest Share Of The Oncologists Market?

North America was the largest region in the oncologists market in 2025. The regions covered in the oncologists market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Oncologists Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=9474&type=smp

Browse Through More Reports Similar to the Global Oncologists Market 2026, By The Business Research Company

Asphalt Additives Global Market Report

https://www.thebusinessresearchcompany.com/report/asphalt-additives-global-market-report

Asphalt Pavers Global Market Report

https://www.thebusinessresearchcompany.com/report/asphalt-pavers-global-market-report

Polymer Coated Fabrics Global Market Report

https://www.thebusinessresearchcompany.com/report/polymer-coated-fabrics-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795